Sera Prognostics, Inc. (SERA) stock
SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
$2.01+0.03 (+1.52%)
Close on Nov 13, 2026Market cap $79.29MP/E –Yield –
Sera Prognostics cash
Cash and short-term investments held at the end of each period.
Sera Prognostics's cash was $44.09M at Sep 30, 2026. For fiscal 2025 it was $39.20M, down 15.2% from the year before. The highest annual figure on record is $105.12M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.20M | -15.2% |
| FY2024 | Dec 31, 2024 | $46.24M | -5.8% |
| FY2023 | Dec 31, 2023 | $49.08M | -40.7% |
| FY2022 | Dec 31, 2022 | $82.70M | -21.3% |
| FY2021 | Dec 31, 2021 | $105.12M | +676.7% |
| FY2020 | Dec 31, 2020 | $13.53M | -36.7% |
| FY2019 | Dec 31, 2019 | $21.39M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $44.09M | +1.8% |
| Q2 FY2026 | Jun 30, 2026 | $46.45M | +15.6% |
| Q1 FY2026 | Mar 31, 2026 | $47.40M | +2.6% |
| Q4 FY2025 | Dec 31, 2025 | $39.20M | -15.2% |
| Q3 FY2025 | Sep 30, 2025 | $43.30M | -13.0% |
| Q2 FY2025 | Jun 30, 2025 | $40.16M | -21.2% |
| Q1 FY2025 | Mar 31, 2025 | $46.20M | -12.8% |
| Q4 FY2024 | Dec 31, 2024 | $46.24M | -5.8% |
| Q3 FY2024 | Sep 30, 2024 | $49.75M | +7.9% |
| Q2 FY2024 | Jun 30, 2024 | $50.94M | -20.2% |
| Q1 FY2024 | Mar 31, 2024 | $52.97M | -25.2% |
| Q4 FY2023 | Dec 31, 2023 | $49.08M | -40.7% |
| Q3 FY2023 | Sep 30, 2023 | $46.12M | -48.1% |
| Q2 FY2023 | Jun 30, 2023 | $63.82M | -40.3% |
| Q1 FY2023 | Mar 31, 2023 | $70.79M | -34.2% |
| Q4 FY2022 | Dec 31, 2022 | $82.70M | -21.3% |
| Q3 FY2022 | Sep 30, 2022 | $88.78M | -26.0% |
| Q2 FY2022 | Jun 30, 2022 | $106.91M | +17.7% |
| Q1 FY2022 | Mar 31, 2022 | $107.55M | +79.2% |
| Q4 FY2021 | Dec 31, 2021 | $105.12M | +676.7% |
| Q3 FY2021 | Sep 30, 2021 | $119.98M | +542.2% |
| Q2 FY2021 | Jun 30, 2021 | $90.85M | +284.5% |
| Q1 FY2021 | Mar 31, 2021 | $60.02M | +180.6% |
| Q4 FY2020 | Dec 31, 2020 | $13.53M | – |
| Q3 FY2020 | Sep 30, 2020 | $18.68M | – |
| Q2 FY2020 | Jun 30, 2020 | $23.63M | – |
| Q4 FY2019 | Dec 31, 2019 | $21.39M | – |
See a number that looks wrong?